Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Clinical trial NCT05555706 · COMPLETED
Trial details
- NCT number
- NCT05555706
- Sponsor
- Shanghai Jiaolian Drug Research and Development Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2024-09-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.